Howard Colman

19PUBLICATIONS
167CO-AUTHORS
Molecular targetsBiological adaptationRegenerative medicine (incl. stem cells)Mining, energy and natural resources lawTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 22, 2026
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.

|Apr 24, 2026
Combination of metronomic oral pazopanib and topotecan for recurrent glioblastoma with and without previous bevacizumab: Results from a phase 2 clinical trial.

|Apr 14, 2026
Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Patrick Y Wen, Donald A Berry, Meredith B Buxton

|Dec 15, 2025
Stereotactic radiosurgery for radiation‑induced meningiomas: long‑term institutional outcomes with patient- and lesion‑level analyses and an updated meta‑analysis.

Saachi Jhandi, Angad S Jhandi, Donald M Cannon

|Dec 01, 2025
STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma.

Howard Colman, Giuseppe Lombardi, Eric T Wong

|Dec 30, 2024
Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma.

Joe S Mendez, Adam L Cohen, Midori Eckenstein

Pageof 4

Frequent Collaborators

4 joint publications

Patrick Y Wen

4 joint publications

Tobias Walbert

4 joint publications

Randy L Jensen

4 joint publications

L Burt Nabors